Supreme Court Keeps Telehealth Abortion Access Intact for Now

The Supreme Court this week allowed nationwide telehealth access to the abortion drug mifepristone to continue, rejecting lower court efforts to restrict its distribution through the mail. Justices Clarence Thomas and Samuel Alito dissented sharply, arguing the decision undercuts the 2022 Dobbs ruling that returned abortion policy to the states.

In a brief emergency order, the court blocked a Fifth Circuit decision that had sought to limit mifepristone prescriptions issued without in-person visits. The move preserves the current system under which women in states with strict bans can obtain the drug through remote providers and have it shipped directly. Data from 2025 shows that more residents of ban states received medication this way than traveled across state lines for procedures. Medication abortions now account for roughly two-thirds of all procedures nationwide.

Thomas wrote that the Comstock Act of 1873 still bars the mailing of drugs intended to produce abortion. He described the applicants as seeking relief from an order that would halt what he called a criminal enterprise. Alito went further, labeling the overall approach a scheme to evade the core holding of Dobbs. Both justices noted that total abortions have risen since the 2022 decision, largely because of expanded mail access rather than clinic visits.

State officials in places with near-total bans had counted on the ability to enforce their own laws once federal courts stepped back after Dobbs. The new order leaves those restrictions harder to apply when pills arrive in plain envelopes from out-of-state pharmacies. Advocates for tighter limits say the ruling effectively nationalizes one method of ending pregnancies even where legislatures have acted.

The Comstock language remains on the books and has never been formally repealed. Thomas’s opinion stressed that federal courts should not grant stays based on lost profits from activity the statute appears to prohibit. Alito’s dissent echoed concerns that lower courts and agencies are finding workarounds that keep the pre-Dobbs regime alive in practice if not in name.

Public health data released earlier this year confirmed the shift: medication abortions rose steadily after 2022, with telehealth filling gaps left by clinic closures in restrictive states. Critics argue this outcome was never contemplated when the court overturned Roe and emphasized democratic control at the state level.

The immediate practical effect is that distribution networks already in place can keep operating without new barriers. Longer term, Thomas and Alito signaled that future cases testing the Comstock Act directly could reach the court. Until then, states seeking to limit mail shipments will have to navigate around the current stay.

The decision arrives amid ongoing legal fights over whether federal drug regulators can maintain broad access rules or whether statutory text from the nineteenth century still governs. For now, the court has chosen to leave the existing channels open while the dissents lay groundwork for renewed scrutiny.